Jill M. Quigley - 23 Jan 2024 Form 4 Insider Report for Terns Pharmaceuticals, Inc. (TERN)

Role
Sr. Advisor & Strategy Officer, Director
Signature
/s/ Bryan Yoon as Attorney-in-Fact for Jill M. Quigley
Issuer symbol
TERN
Transactions as of
23 Jan 2024
Net transactions value
$0
Form type
4
Filing time
25 Jan 2024, 19:18:46 UTC
Previous filing
17 Nov 2023
Next filing
14 Jun 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TERN Common Stock Award $0 +15,000 +100% $0.000000 30,000 23 Jan 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each share is represented by a Restricted Stock Unit ("RSU"). 100% of the RSUs will vest on January 1, 2025 (the "Vesting Date"), subject to the Reporting Person's continued service to the Issuer through the Vesting Date.